Current Edition

cybersecurity

The Four Trends Set to Disrupt Highly Regulated Industries in 2023

Bob Tilling, VP Global Sales at Kallik identifies four trends set to disrupt manufacturers in highly regulated industries in 2023: the industrial metaverse, the need …

Continue Reading →
biologics

Cutting-edge Formulation is Needed to Enable the Next Generation of Oral Biologics

An Introduction to Oral Solid Dose Traditionally, the pharmaceutical market has been dominated by oral drug delivery – whether oral solid dose (OSD) or liquid …

Continue Reading →
coding

Individual Device Identification: Coding and Marking for the New Dimension in Patient Health and Safety

Counterfeit products and product piracy are serious issues for the pharmaceutical industry – but recent product marking requirements in developed economies, including the US and …

Continue Reading →
approach

Why an Outcome-driven Approach to Supply Chain is a Strategic Advantage for Pharmaceutical Businesses

Since 2020, the pharmaceutical industry has been grappling with frequent and rapid changes, shifting customer demands and increasing costs. In response, organisations have stepped up …

Continue Reading →
ARIPO

Intellectual Property Matters for Economic, Social, Technological, Scientific, and Industrial Development

Q: SPL – Please tell us about ARIPO. Why was ARIPO formed and what are your core functions and visions of ARIPO? A: The African …

Continue Reading →
development

IPI speaks with experts at PharmaLex on Integrated Product Development

Q: Can we start with a brief history of PharmaLex, what are your key offerings into the industry? A: PharmaLex was established 25 years ago …

Continue Reading →
Biotechs

How Are Emerging Biotechs Harnessing Strategic Partnerships to Strengthen Their Journey to Commercialisation?

Forecasted to reach $108 billion by 2023, the global pharmaceutical services outsourcing market is currently undergoing incredible levels of growth. Organisations that are reaping the …

Continue Reading →
data

Navigating the Data-driven Future of Life Sciences Regulatory Processes: Who Will Take the Lead?

Generis hosted a live video discussion with a panel of industry thought leaders from BioNTech, Bayer, Iperion – a Deloitte business, and Beczek. COM to …

Continue Reading →
development

Navigating the Changing Oral Solid Dose Landscape

Oral solid dose (OSD) forms have accounted for the lion’s share of the pharmaceutical market for decades, thanks to their easy administration leading to patient …

Continue Reading →
biotechnology

Into the Future with Next-generation Small Molecules

Heightened interest in small molecules is likely to continue in 2023 and beyond as several biotech companies look beyond biologics to bring medicines to patients …

Continue Reading →